NEW YORK (Reuters Health) – Treatment with the nonsteroidal selective estrogen receptor modulator raloxifene may heighten the risk of venous thromboembolic events and stroke deaths in postmenopausal women…
NEW YORK (Reuters Health) – In high-risk atrial fibrillation patients who are candidates for anticoagulation, stroke usually occurs if warfarin is not used or drug levels are subtherapeutic,…
NEW YORK (Reuters Health) – In the largest cohort study to date, statin treatment was found to reduce the incidence of Alzheimer’s disease, regardless of the drug’s lipophilicity…
By David Douglas NEW YORK (Reuters Health) – There appears to be a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced relief of anxiety, Swedish…
Neelam Misra, MD, Assistant Medical Director, Manhattan Total Health, discusses acupuncture and effects on the autonomic nervous system. References and Resources Kawakita K, Shinbara H, Imai K, Fukuda…
S. Ausim Azizi, MD, PhD, Chairperson/Professor, Department of Neurology, Temple University School of Medicine, discusses Parkinson’s Disease. References and Resources Tessa C, Giannelli M, Nave RD, Lucetti C,…
Current long-term use of calcium channel blockers was associated with a significantly reduced risk of a Parkinson disease diagnosis, while the risk was not materially altered for users…
Marc R. Rosen, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, describes the relatively new technique of minimally invasive skull base surgery…
Jack Stern, MD, PhD, Neurosurgeon, Spine Specialist, discusses whether surgeons are accurately diagnosing lumbar disc pathology before proceeding to spinal fusion or artificial disc insertion. There has been…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses therapeutic options for neurofibromatosis and their progression from surgery, chemotherapy or bracing/amputation to targeted drug treatments.…